Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell CarcinomaVicki Goodman, Richard Pazdur, Sophia Abraham et al.|Clinical Cancer Research|2007Cited by 495
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.Martin H. Cohen, Richard Pazdur, Grant Williams et al.|PubMed|2002Cited by 469